XinThera
Latest round
- Series B
Last raised
- Aug 2021
Total raised
- $50M
Investors
- 3
About XinThera
Based in San Diego, US, and founded in 2021, XinThera, LLC. provides precision medicines to treat cancer and immunological diseases. As of 2022, the company was headed by its CEO Chris LeMasters. The company offers new opportunities and new therapies that can be used to treat cancer and immunological diseases. The firm designs medicines for the patient by using advanced computational chemistry technologies.
Who invested in XinThera
3 investors across 1 round
See all investors in XinThera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Aug 4, 2021
Amount
$50M
Investors
Questions about XinThera
Who invested in XinThera?
XinThera has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XinThera raised?
XinThera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did XinThera last raise money?
XinThera's most recent round on record is a Series B, in Aug 2021.
What does XinThera do?
Based in San Diego, US, and founded in 2021, XinThera, LLC.
Where is XinThera headquartered?
XinThera is headquartered in San Diego, US.
Which VCs invest in companies like XinThera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at XinThera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like XinThera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.